Clinical Trial

Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of the study is to test a treatment strategy with currently approved drugs to see if it is practical to administer the available drugs in a new way that researchers hope could be more effective in treating metastatic breast cancer.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2024-05-07; most recent amendment 2025-12-02.
Trial Details
NCT Number NCT06409390
Lead Sponsor H. Lee Moffitt Cancer Center and Research Institute
Conditions Metastatic Breast Cancer
Enrollment 15 participants
Start Date 2024-08-14
Primary Completion 2027-04 (estimated)
Study Completion 2027-04 (estimated)
Updated on ClinicalTrials.gov 2025-12-04